Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

China flag China · Delayed Price · Currency is CNY
73.50
+0.71 (0.98%)
At close: Feb 12, 2026
Market Cap4.87B +83.2%
Revenue (ttm)336.73M +22.0%
Net Income101.91M +49.3%
EPS1.54 +47.4%
Shares Out66.70M
PE Ratio47.41
Forward PEn/a
Dividend0.60 (0.82%)
Ex-Dividend DateMay 30, 2025
Volume694,673
Average Volume1,419,190
Open73.00
Previous Close72.79
Day's Range72.40 - 74.56
52-Week Range41.40 - 92.50
Beta-0.05
RSI53.10
Earnings DateApr 28, 2026

About SHE:301033

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal,... [Read more]

Sector Healthcare
Founded 2008
Employees 337
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301033
Full Company Profile

Financial Performance

In 2024, SHE:301033's revenue was 278.44 million, an increase of 20.61% compared to the previous year's 230.87 million. Earnings were 78.85 million, an increase of 92.90%.

Financial Statements